Hear from a panel of experts from across 3 key life science cities in China.

In 2016 China announced over $9.2 billion investment in life science over 15 years and by 2020 it is expected to grow its pharmaceutical market volume to $22 billion USD, becoming the second-largest market after the United States.

To help East of England businesses capitalise on this growth, Exemplas Trade Services (ETSL) has invited key members of the Department for International Trade (DIT) life science team in China to meet with companies from the region. After the morning’s presentations there will be an opportunity to have 1-2-1 meetings with the experts.*

The workshop topics:**

• Opportunities for UK life science companies

• Regulatory and Healthcare policy

• Intellectual property

• Medical product registration & approval processes

• Support available to UK Companies (from DIT and other organisations)

• Case studies from AstraZeneca and Wuxi AppTec

The speakers:

• Kevin Holland, Minister-Counsellor. Director for Life Science and Healthcare,

British Embassy Beijing, DIT

• Simon Mellon, HM Consul and Assistant Director for Life Science and Healthcare,

South China, DIT

• Qionger He, Trade and Investment Manager for Life Science and Healthcare,

East China, DIT

• Anna Fischer, Business Consultant, CISEMA